Happy Patients with ZEISS AT LISA tri family
Tired of seeing those
unhappy patients?
Happy Patients with ZEISS AT LISA tri family
inspirationMADE BY ZEISS
Switch now to see more happy patients ZEISS AT LISA tri family

Contact us to switch

inspirationMADE BY ZEISS
Happy Patients with ZEISS AT LISA tri family
Tired of seeing those
unhappy patients?
Happy Patients with ZEISS AT LISA tri family
inspirationMADE BY ZEISS
Switch now to see more happy patients ZEISS AT LISA tri family

Contact us to switch

inspirationMADE BY ZEISS
Happy Patients with ZEISS AT LISA tri family
Tired of seeing those
unhappy patients?
Happy Patients with ZEISS AT LISA tri family
inspirationMADE BY ZEISS
Switch now to see more happy patients ZEISS AT LISA tri family

Contact us to switch

inspirationMADE BY ZEISS

Why face unhappy patients?

Switch now to ZEISS AT LISA tri family for more patient satisfaction

ZEISS AT LISA tri 839MP and AT LISA tri toric 939MP

ZEISS AT LISA tri 839MP and AT LISA tri toric 939MP

Have you ever wondered why some patients are unhappy despite a successful cataract surgery? Have you felt frustrated when looking into those angry and disappointed faces and listening to complaints?
Have you ever wished you could give your patients what they expect and make them really happy?

If you want to see better refractive outcomes and more smiling faces, try the AT LISA tri family from ZEISS, the global market leader in trifocal IOLs.

Schedule a demo

What makes ZEISS LISA tri family a preferred choice for you and your patients?

A very high or extremely high patient satisfaction

Clinical studies and patient testimonials show clearly that patients treated with AT LISA tri IOL are very happy with their vision and would recommend it to their friends and family.

Over 90 % of all patients treated with AT LISA tri said to be very happy with their post-operative visual performance at all distances.1

A very high patient referral rate

High patient satisfaction leads to a high patient referral rate. A study performed by Kohnen, Titke and Boehm shows that 92% of patients treated with AT LISA tri would choose the same IOL again and recommend it to others.2

According to an unpublished Mexican study the patient referral rate reaches even 97%.3

A high level of spectacle independence at all distances

An extensive market research study with over 2,900 respondents confirmed that spectacle Independence is extremely important to patients for most daily activities including shaving or putting on make-up, preparing and eating meals, sports and outdoor hobbies. This means patients require freedom from glasses for near, intermediate and far distances.4

AT LISA tri provides excellent levels of spectacle independence at all three distances, as shown in clinical data: complete spectacle freedom is higher than 90%.5

All patients reach complete spectacle independence at far and intermediate distances according to a recent study performed by Kohnen et al.6

Request the Clinical Studies

What makes ZEISS AT LISA tri a safe solution for you and your patients?

Since its launch in 2012, numerous scientific studies have been published in peer-reviewed journals (over 25 publications), confirming the excellent visual performance of the AT LISA tri family from ZEISS.

For example, a recent study by Alfonso et al. examined the performance of AT LISA tri in a large sample (n=204) showing extraordinary 6-month post op data with particularly good visual acuity at 40 and 50 cm.7

Scientific publications focus on a range of topics:
  • outstanding visual acuity
  • high level of patient satisfaction and spectacle independence
  • strong contrast sensitivity performance
  • proven outcomes with large samples

A summary of results from scientific publications can be found in the Clinical Leaflet.  

Request the latest Clinical Leaflet

Why is ZEISS AT LISA tri family the leading trifocal technology?

ZEISS AT LISA tri family world map

AT LISA tri family IOLs are used in most countries around the world

AT LISA tri and AT LISA tri toric are the most frequently implanted trifocal IOLs in the world making the ZEISS AT LISA tri family the leading trifocal technology on a global level.

In 2016 AT LISA tri IOLs were sold in 73 countries worldwide. Based on the proven MICS platform, AT LISA tri has been highly commended by many reputable cataract surgeons around the globe.

Doctors value excellent visual results, especially for intermediate distance, as well as good night vision and low level of halos and glare. They appreciate the fact that patient consultation and selection have become easier with AT LISA tri and that they can offer their patients complete spectacle independence.

They also report an increased patient referral rate with AT LISA tri IOLs. The lens allows them to meet the expectations of even the most demanding patients - those who are well informed and expect the best outcomes from a cataract surgery.

With the toric version doctors can treat more patients and also offer freedom from glasses to astigmatic patients. Moreover, surgeons value the ease of use of the platform, the smooth unfolding of the lens in the capsular bag, as well as its stability in the eye.

Loading the player...

See what else doctors say about ZEISS AT LISA tri family:

Watch the testimonial video.

Why is ZEISS AT LISA tri family a reliable technology?

ZEISS AT LISA tri family cinematography

ZEISS lenses used in cinematography.

With AT LISA tri and AT LISA tri toric being the most widely used trifocal IOLs in the world, ZEISS is the clear market leader in trifocal technology worldwide. It confirms the company's position as one of the world's leading brands in medical technology and one the most trusted and respected precision optics brands.

The company has a long tradition of manufacturing high-quality lenses for everything from glasses to cameras, telescopes, binoculars and intraocular lenses.

ZEISS' aim is to give patients perfect vision by creating an optimum dialog between the eye and the visual device — the lens. ZEISS enables eye surgeons to perform at their very best: 15 million cataract operations are performed using surgical solutions from ZEISS every year.

Our goal is to become your partner of choice when it comes to restoring the vision and improving the quality of life of your patients. Get in touch with our sales representative to learn more about the leading trifocal technology, AT LISA tri family and other ZEISS solutions for cataract surgery.

Let our ZEISS Sales Representative contact you

Contact us

Locations, Directions, Numbers

more

1 E. Law, 2014. Clinical Outcomes With A New Trifocal IOL, EJO, 2014 Jul-Aug;24(4):501-8.

2 Kohnen, Titke and Boehm, 2016. Trifocal Intraocular Lens Implantation to Treat Visual Demands in Various Distances Following Lens Removal. Am Journal Ophthalmology. 2016; 161:71-77.

3 Data on file

4 Market Research by Exevia Market Research Agency for CZM, 2016. Data on file.

5 Mendicute et al, 2016. Evaluation of visual outcomes and patient satisfaction after implantation of a diffractive trifocal intraocular lens. J Cataract Refract Surg. 2016 Feb;42(2):203-10.

6 Kohnen, Titke and Boehm, 2016. Trifocal Intraocular Lens Implantation to treat Visual Demands in Various Distances Following Lens Removal. Am Journal Ophthalmology. 2016; 161:71-77.

7 Alfonso et al., 2016. Visual function after implantation of a diffractive aspheric trifocal intraocular lens. European Journal of Ophthalmology 2016; Jan 18:0.

We use cookies on this site. Cookies are small text files that are stored on your computer by websites. Cookies are widely used and help to optimize the pages that you view. By using this site, you agree to their use. more